MINERVA 35 micrograms, coated tablet 63 tablets
Active ingredients: Cyproterone acetate, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet63 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MINERVA 35 microgrammes, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) PVC aluminium de 21 comprimé(s)
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62003590CIP73450689CIP133400934506895Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE CYPROTÉRONEcomprimé | 2,000 mg · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé | 0,035 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.